Related Experiment Video
Updated: May 19, 2026
08:15
Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
Published on: May 10, 2024
Manipulating JNK signaling with (--)-zuonin A
Tamer S Kaoud1, Heekwang Park, Shreya Mitra
1Division of Medicinal Chemistry, The University of Texas at Austin, Austin, Texas 78712, United States.
ACS Chemical Biology
|August 25, 2012
Summary
(-)-Zuonin A, a natural product, was synthesized and found to partially inhibit c-Jun N-terminal kinases (JNKs) by weakening c-Jun binding. This compound affects JNK activation and downstream signaling, offering insights into lignan activity.
Area of Science:
- Biochemistry and Molecular Biology
- Natural Product Chemistry
- Signal Transduction
Background:
- The c-Jun N-terminal kinases (JNKs) are crucial in cellular stress responses and signaling pathways.
- Identifying specific inhibitors of JNK activity, particularly those targeting protein-protein interactions, is of therapeutic interest.
- Virtual screening has emerged as a powerful tool for discovering novel bioactive compounds.
Purpose of the Study:
- To report the asymmetric synthesis of the natural product (-)-zuonin A and its enantiomer (+)-zuonin A.
- To investigate the mechanism by which (-)-zuonin A inhibits JNK activity and its downstream effects.
- To explore the potential of (-)-zuonin A as a chemical probe for studying JNK signaling and protein-protein interactions.
Main Methods:
- Asymmetric synthesis of (-)-zuonin A and (+)-zuonin A.
- Kinetic analysis of JNK inhibition and c-Jun phosphorylation.
- Molecular docking and dynamics simulations to predict binding sites.
- Cell-based assays using HEK293 and MDA-MB-231 cells to assess JNK activation and downstream effects.
Main Results:
- (-)-Zuonin A was synthesized and demonstrated partial competitive inhibition of c-Jun phosphorylation by JNK.
- (-)-Zuonin A weakens the interaction between c-Jun and JNK, and inhibits JNK activation by MKK4 and MKK7.
- Binding of (-)-zuonin A is predicted to be in the D-recruitment site (DRS) of JNK, impacting JNK2 activity and cell migration.
Conclusions:
- (-)-Zuonin A is a novel inhibitor of JNK signaling that acts by modulating protein-protein interactions within the MAPK cascade.
- The findings suggest that the biological activities of related lignans may stem from similar mechanisms of disrupting JNK pathway interactions.
- (-)-Zuonin A serves as a valuable tool for chemical genetic studies and warrants further investigation for therapeutic potential.
Related Concept Videos
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
03:14Notch Signaling Pathway
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
03:14Notch Signaling Pathway
The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...